Safety, pharmacodynamic, and antitumor activity of tidutamab, an SSTR2 x CD3 bispecific antibody, in subjects with advanced neuroendocrine tumors Meeting Abstract
| Authors: | El-Rayes, B. F.; Hendifar, A. E.; Pant, S.; Wilky, B. A.; Reilley, M. J.; Benson, A. B.; Chow, W. A.; Konda, B.; Starr, J.; Ahn, D. H.; Kunz, P. L.; Strosberg, J. R.; Eads, J. R.; Perez, K. J.; Raj, N. P.; Fisher, G. A.; Chollate, S.; Fleener, C. A.; Ding, Y.; Tang, Z. |
| Abstract Title: | Safety, pharmacodynamic, and antitumor activity of tidutamab, an SSTR2 x CD3 bispecific antibody, in subjects with advanced neuroendocrine tumors |
| Meeting Title: | 14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society (NANETS 2021) |
| Journal Title: | Pancreas |
| Volume: | 51 |
| Issue: | 3 |
| Meeting Dates: | 2021 Nov 4-6 |
| Meeting Location: | Virtual |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-03-01 |
| Start Page: | E58 |
| Language: | English |
| ACCESSION: | WOS:000819123700109 |
| PROVIDER: | wos |
| PUBMED: | 35584389 |
| DOI: | 10.1097/MPA.0000000000001979 |
| Notes: | Meeting Abstract: T-1 -- Located in section labeled "Trials in Progress" -- Source: Wos |
